Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) VP Elizabeth D. Phillips sold 1,850 shares of Kewaunee Scientific stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total value of $100,214.50. Following the completion of the transaction, the vice president now directly owns 13,591 shares of the company’s stock, valued at $736,224.47. This represents a 11.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Kewaunee Scientific Price Performance
Shares of Kewaunee Scientific stock traded down $0.50 during midday trading on Wednesday, reaching $53.25. The company had a trading volume of 11,216 shares, compared to its average volume of 17,218. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The stock has a fifty day simple moving average of $38.52 and a 200 day simple moving average of $42.32. Kewaunee Scientific Co. has a 1-year low of $24.49 and a 1-year high of $56.95. The company has a market capitalization of $152.93 million, a price-to-earnings ratio of 8.44 and a beta of 0.80.
Institutional Investors Weigh In On Kewaunee Scientific
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Barclays PLC acquired a new position in shares of Kewaunee Scientific during the third quarter valued at $121,000. Geode Capital Management LLC raised its holdings in Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after purchasing an additional 1,941 shares during the last quarter. State Street Corp acquired a new position in Kewaunee Scientific during the 3rd quarter valued at about $266,000. De Lisle Partners LLP lifted its position in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after purchasing an additional 11,511 shares during the period. Finally, Ritholtz Wealth Management boosted its stake in shares of Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after purchasing an additional 2,156 shares during the last quarter. 32.69% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Read Our Latest Research Report on KEQU
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- Airline Stocks – Top Airline Stocks to Buy Now
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Calculate Options Profits
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is a Stock Market Index and How Do You Use Them?
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.